Engineered Supramolecular Surfaces for High-Throughput Polymorphism Screening of Active Pharmaceutical Ingredients

Fonte Standard Gras
Identifiant

Unité de recherche

INNOSUISSE

Numéro de projet

9634.2;6 PFNM-NM

Titre du projet

Engineered Supramolecular Surfaces for High-Throughput Polymorphism Screening of Active Pharmaceutical Ingredients

Titre du projet anglais

Engineered Supramolecular Surfaces for High-Throughput Polymorphism Screening of Active Pharmaceutical Ingredients

Textes relatifs à ce projet

	Allemand	Français	Italien	Anglais
Description succincte	-	-	-
Résumé des résultats (Abstract)	-	-	-

Textes saisis

Catégorie	Texte
Description succincte (Anglais)	Engineered Supramolecular Surfaces for High-Throughput Polymorphism Screening of Active Pharmaceutical Ingredients
Résumé des résultats (Abstract) (Anglais)	Polymorphism is defined as the ability of a substance to exist as two or more crystalline phases; it is of very high interest in the production of active pharmaceutical ingredients. This project aims to develop a new technological approach, based on solid experimental and technical foundations, dedicated to provide the pharmaceutical industry tailor-made solutions for high-throughput screening of polymorphic forms of APIs.

Catégorie

Texte

Description succincte
(Anglais)

Engineered Supramolecular Surfaces for High-Throughput Polymorphism Screening of Active Pharmaceutical Ingredients

Résumé des résultats (Abstract)
(Anglais)

Polymorphism is defined as the ability of a substance to exist as two or more crystalline phases; it is of very high interest in the production of active pharmaceutical ingredients. This project aims to develop a new technological approach, based on solid experimental and technical foundations, dedicated to provide the pharmaceutical industry tailor-made solutions for high-throughput screening of polymorphic forms of APIs.